Serum Homocysteine and Vascular Calcification: Advances in Mechanisms, Related Diseases, and Nutrition

키워드

참고문헌 (148)

1. Roth GA, "Global burden of cardiovascular diseases and risk factors, 1990-2019 : update from the GBD 2019 Study", J Am Coll Cardiol, 76, pp.2982~3021 (2020)
2. Virani SS, "Heart disease and stroke statistics-2021 update : a report from the American Heart Association", Circulation, 143, pp.e254~e743 (2021)
3. Global Burden of Disease Cancer Collaboration, "Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017 : a systematic analysis for the Global Burden of Disease Study", JAMA Oncol, 5, pp.1749~1768 (2019)
4. GBD 2017 Causes of Death Collaborators, "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.1736~1788 (2018)
5. Norgren L, "Inter-Society Consensus for the Management of Peripheral Arterial Disease(TASC II)", J Vasc Surg, 45(Suppl S), pp.S5~S67 (2007)
6. McDermott MM, "Ankle-brachial index screening to improve health outcomes : where is the evidence?", Ann Intern Med, 159, pp.362~363 (2013)
7. Vliegenthart R, "Coronary calcification improves cardiovascular risk prediction in the elderly", Circulation, 112, pp.572~577 (2005)
8. Rumberger JA, "Using noncontrast cardiac CT and coronary artery calcification measurements for cardiovascular risk assessment and management in asymptomatic adults", Vasc Health Risk Manag, 6, pp.579~591 (2010)
9. Bos D, "Leveraging the coronary calcium scan beyond the coronary calcium score", Eur Radiol, 28, pp.3082~3087 (2018)
10. Stein JH, "Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk : a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine", J Am Soc Echocardiogr, 21, pp.93~111 (2008)
11. Chambless LE, "Carotid wall thickness is predictive of incident clinical stroke : the Atherosclerosis Risk in Communities(ARIC)Study", Am J Epidemiol, 151, pp.478~487 (2000)
12. Van Campenhout A, "Role of homocysteine in aortic calcification and osteogenic cell differentiation", Atherosclerosis, 202, pp.557~566 (2009)
13. Moghadasian MH, "Homocyst(e)ine and coronary artery disease : clinical evidence and genetic and metabolic background", Arch Intern Med, 157, pp.2299~2308 (1997)
14. Schalinske KL, "Homocysteine imbalance : a pathological metabolic marker", Adv Nutr, 3, pp.755~762 (2012)
15. Skovierova H, "The molecular and cellular effect of homocysteine metabolism imbalance on human health", Int J Mol Sci, 17, pp.1733~ (2016)
16. Welch GN, "Homocysteine and atherothrombosis", N Engl J Med, 338, pp.1042~1050 (1998)
17. Handy DE, "Homocysteine and atherothrombosis : diagnosis and treatment", Curr Atheroscler Rep, 5, pp.276~283 (2003)
18. Rennenberg RJ, "Vascular calcifications as a marker of increased cardiovascular risk : a meta-analysis", Vasc Health Risk Manag, 5, pp.185~197 (2009)
19. Detrano R, "Coronary calcium as a predictor of coronary events in four racial or ethnic groups", N Engl J Med, 358, pp.1336~1345 (2008)
20. Shioi A, "Plaque calcification during atherosclerosis progression and regression", J Atheroscler Thromb, 25, pp.294~303 (2018)
21. Karger AB, "Association between homocysteine and vascular calcification incidence, prevalence, and progression in the MESA cohort", J Am Heart Assoc, 9, pp.e013934~ (2020)
22. Roijers RB, "Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries", Am J Pathol, 178, pp.2879~2887 (2011)
23. Nadra I, "Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways : a vicious cycle of inflammation and arterial calcification?", Circ Res, 96, pp.1248~1256 (2005)
24. Otsuka F, "Has our understanding of calcification in human coronary atherosclerosis progressed?", Arterioscler Thromb Vasc Biol, 34, pp.724~736 (2014)
25. Wu B, "How does calcification influence plaque vulnerability? : insights from fatigue analysis", ScientificWorldJournal, 2014, pp.417324~ (2014)
26. Kelly-Arnold A, "Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries", Proc Natl Acad Sci U S A, 110, pp.10741~10746 (2013)
27. Vancheri F, "Coronary artery microcalcification: imaging and clinical implications", Diagnostics (Basel), 9, pp.125~ (2019)
28. Nissen SE, "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis : the ASTEROID trial", JAMA, 295, pp.1556~1565 (2006)
29. Banach M, "Impact of statin therapy on coronary plaque composition : a systematic review and meta-analysis of virtual histology intravascular ultrasound studies", BMC Med, 13, pp.229~ (2015)
30. Knez A, "Relation of coronary calcium scores by electron beam tomography to obstructive disease in 2, 115 symptomatic patients", Am J Cardiol, 93, pp.1150~1152 (2004)
31. Sarwar A, "Diagnostic and prognostic value of absence of coronary artery calcification", JACC Cardiovasc Imaging, 2, pp.675~688 (2009)
32. BudoffMJ, "Long-term prognosis associated with coronary calcification : observations from a registry of 25, 253 patients", J Am Coll Cardiol, 49, pp.1860~1870 (2007)
33. Mitchell JD, "Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke : the Walter Reed Cohort Study", JACC Cardiovasc Imaging, 11, pp.1799~1806 (2018)
34. Criqui MH, "Calcium density of coronary artery plaque and risk of incident cardiovascular events", JAMA, 311, pp.271~278 (2014)
35. Alfrey AC, "Role of phosphate and pyrophosphate in soft tissue calcification", Adv Exp Med Biol, 103, pp.187~193 (1978)
36. Bostrom K, "Bone morphogenetic protein expression in human atherosclerotic lesions", J Clin Invest, 91, pp.1800~1809 (1993)
37. McCullough PA, "Amplification of atherosclerotic calcification and Monckeberg’s sclerosis : a spectrum of the same disease process", Adv Chronic Kidney Dis, 15, pp.396~412 (2008)
38. Schoppet M, "Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg’s sclerosis and atherosclerosis", J Clin Endocrinol Metab, 89, pp.4104~4112 (2004)
39. Tanimura A, "Calcification in atherosclerosis. I. Human studies", J Exp Pathol, 2, pp.261~273 (1986)
40. Tanimura A, "Calcification in atherosclerosis. II. Animal studies", J Exp Pathol, 2, pp.275~297 (1986)
41. Proudfoot D, "Apoptosis regulates human vascular calcification in vitro : evidence for initiation of vascular calcification by apoptotic bodies", Circ Res, 87, pp.1055~1062 (2000)
42. Kim KM, "Calcification of matrix vesicles in human aortic valve and aortic media", Fed Proc, 35, pp.156~162 (1976)
43. Golub EE, "Role of matrix vesicles in biomineralization", Biochim Biophys Acta, 1790, pp.1592~1598 (2009)
44. New SE, "Role of extracellular vesicles in de novo mineralization : an additional novel mechanism of cardiovascular calcification", Arterioscler Thromb Vasc Biol, 33, pp.1753~1758 (2013)
45. Balcerzak M, "The roles of annexins and alkaline phosphatase in mineralization process", Acta Biochim Pol, 50, pp.1019~1038 (2003)
46. Anderson HC, "Molecular biology of matrix vesicles", Clin Orthop Relat Res, (314), pp.266~280 (1995)
47. Parhami F, "Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation : a possible explanation for the paradox of arterial calcification in osteoporotic patients", Arterioscler Thromb Vasc Biol, 17, pp.680~687 (1997)
48. Raggi P, "Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease", Clin J Am Soc Nephrol, 3, pp.836~843 (2008)
49. Escobar Guzman LF, "Pathophysiological and genetic aspects of vascular calcification", Cardiol Res Pract, 2020, pp.5169069~ (2020)
50. Reynolds JL, "Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations : a potential mechanism for accelerated vascular calcification in ESRD", J Am Soc Nephrol, 15, pp.2857~2867 (2004)
51. Proudfoot D, "Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression", Arterioscler Thromb Vasc Biol, 18, pp.379~388 (1998)
52. Shanahan CM, "Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells", Circ Res, 73, pp.193~204 (1993)
53. Giachelli CM, "Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques", J Clin Invest, 92, pp.1686~1696 (1993)
54. Ikeda T, "Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta", J Clin Invest, 92, pp.2814~2820 (1993)
55. Shanahan CM, "High expression of genes for calcification-regulating proteins in human atherosclerotic plaques", J Clin Invest, 93, pp.2393~2402 (1994)
56. Dhore CR, "Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques", Arterioscler Thromb Vasc Biol, 21, pp.1998~2003 (2001)
57. Byon CH, "Molecular mechanisms of vascular calcification in chronic kidney disease : the link between bone and the vasculature", Curr Osteoporos Rep, 13, pp.206~215 (2015)
58. Xiao G, "Cooperative interactions between activating transcription factor 4 and Runx2", Cbfa1stimulate osteoblast-specific osteocalcin gene expression, 2005, pp.280, 30689~30696
59. Kim KM, "Apoptosis and calcification", Scanning Microsc, 9, pp.1137~1178 (1995)
60. Jakubowski H, "Metabolism of homocysteine thiolactone in human cell cultures : possible mechanism for pathological consequences of elevated homocysteine levels", J Biol Chem, 272, pp.1935~1942 (1997)
61. Mercie P, "Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features", Apoptosis, 5, pp.403~411 (2000)
62. Cheng Z, "Hyperhomocysteinemia and endothelial dysfunction", Curr Hypertens Rev, 5, pp.158~165 (2009)
63. Naseem KM, "The role of nitric oxide in cardiovascular diseases", Mol Aspects Med, 26, pp.33~65 (2005)
64. Leeuwenburgh C, "Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima", J Biol Chem, 272, pp.1433~1436 (1997)
65. Bian K, "Vascular system: role of nitric oxide in cardiovascular diseases", J Clin Hypertens (Greenwich), 10, pp.304~310 (2008)
66. Yang Q, "Imbalance of homocysteine and H2S : significance, mechanisms, and therapeutic promise in vascular injury", Oxid Med Cell Longev, 2019, pp.7629673~ (2019)
67. Pushpakumar S, "Endothelial dysfunction : the link between homocysteine and hydrogen sulfide", Curr Med Chem, 21, pp.3662~3672 (2014)
68. Kanagy NL, "Vascular biology of hydrogen sulfide", Am J Physiol Cell Physiol, 312, pp.C537~C549 (2017)
69. Li JJ, "Homocysteine Triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter", Int J Mol Sci, 16, pp.12560~12577 (2015)
70. Li MH, "Disturbance of endogenous hydrogen sulfide generation and endoplasmic reticulum stress in hippocampus are involved in homocysteine-induced defect in learning and memory of rats", Behav Brain Res, 262, pp.35~41 (2014)
71. Tang XQ, "Inhibition of endogenous hydrogen sulfide generation is associated with homocysteine-induced neurotoxicity : role of ERK1", 2 activation, 2011, pp.45, 60~67
72. Chen S, "Homocysteine induces mitochondrial dysfunction involving the crosstalk between oxidative stress and mitochondrial pSTAT3 in rat ischemic brain", Sci Rep, 7, pp.6932~ (2017)
73. Li M, "Mitochondria homeostasis and vascular medial calcification", Calcif Tissue Int, 109, pp.113~120 (2021)
74. Zhang J, "ROS and ROS-mediated cellular signaling", Oxid Med Cell Longev, 2016, pp.4350965~ (2016)
75. Fleury C, "Mitochondrial reactive oxygen species in cell death signaling", Biochimie, 84, pp.131~141 (2002)
76. Yu EP, "The role of mitochondrial DNA damage in the development of atherosclerosis", Free Radic Biol Med, 100, pp.223~230 (2016)
77. Slater AF, "Signalling mechanisms and oxidative stress in apoptosis", Toxicol Lett, 82-83, pp.149~153 (1995)
78. Austin RC, "Homocysteine-dependent alterations in mitochondrial gene expression, function and structure : homocysteine and H2O2 act synergistically to enhance mitochondrial damage", J Biol Chem, 273, pp.30808~30817 (1998)
79. Byon CH, "Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling", J Biol Chem, 283, pp.15319~15327 (2008)
80. Kurozumi A, "IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2", Bone, 124, pp.53~61 (2019)
81. Henaut L, "Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification", Expert Opin Ther Targets, 20, pp.89~105 (2016)
82. Wen C, "Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification", Int J Cardiol, 168, pp.2242~2247 (2013)
83. Moore KJ, "Macrophages in atherosclerosis : a dynamic balance", Nat Rev Immunol, 13, pp.709~721 (2013)
84. Komohara Y, "Contribution of macrophage polarization to metabolic diseases", J Atheroscler Thromb, 23, pp.10~17 (2016)
85. Puri R, "Impact of statins on serial coronary calcification during atheroma progression and regression", J Am Coll Cardiol, 65, pp.1273~1282 (2015)
86. Raber L, "Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries(IBIS-4) : a serial intravascular ultrasonography study", Eur Heart J, 36, pp.490~500 (2015)
87. Sun Y, "Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification", Circ Res, 111, pp.543~552 (2012)
88. Savinov AY, "Transgenic overexpression of tissue-nonspecific alkaline phosphatase(TNAP)in vascular endothelium results in generalized arterial calcification", J Am Heart Assoc, 4, pp.e002499~ (2015)
89. Bouletreau PJ, "Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells : implications for fracture healing", Plast Reconstr Surg, 109, pp.2384~2397 (2002)
90. Mody N, "Oxidative stress modulates osteoblastic differentiation of vascular and bone cells", Free Radic Biol Med, 31, pp.509~519 (2001)
91. Henze LA, "Impact of C-reactive protein on osteo-", chondrogenic transdifferentiation and calcification of vascular smooth muscle cells, 2019, pp.11, 5445~5462
92. Cola C, "Regulatory role of endothelium in the expression of genes affecting arterial calcification", Biochem Biophys Res Commun, 320, pp.424~427 (2004)
93. Sakamoto M, "Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy", Circ Res, 99, pp.1411~1418 (2006)
94. Dong Y, "Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo", Diabetes, 59, pp.1386~1396 (2010)
95. Tabas I, "The role of endoplasmic reticulum stress in the progression of atherosclerosis", Circ Res, 107, pp.839~850 (2010)
96. Olas B, "Hydrogen sulfide decreases the plasma lipid peroxidation induced by homocysteine and its thiolactone", Mol Cell Biochem, 404, pp.39~43 (2015)
97. Hofmann MA, "Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model", J Clin Invest, 107, pp.675~683 (2001)
98. Papatheodorou L, "Vascular oxidant stress and inflammation in hyperhomocysteinemia", Antioxid Redox Signal, 9, pp.1941~1958 (2007)
99. Fu Y, "Hyperhomocysteinaemia and vascular injury : advances in mechanisms and drug targets", Br J Pharmacol, 175, pp.1173~1189 (2018)
100. Lee SJ, "Vascular calcification-new insights into its mechanism", Int J Mol Sci, 21, pp.2685~ (2020)
101. Iyemere VP, "Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification", J Intern Med, 260, pp.192~210 (2006)
102. Wu JT, "Circulating homocysteine is an inflammation marker and a risk factor of life-threatening inflammatory diseases", J Biomed Lab Sci, 19, pp.107~111 (2007)
103. Graham IM, "Plasma homocysteine as a risk factor for vascular disease : the European Concerted Action Project", JAMA, 277, pp.1775~1781 (1997)
104. Stampfer MJ, "A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians", JAMA, 268, pp.877~881 (1992)
105. Nygard O, "Plasma homocysteine levels and mortality in patients with coronary artery disease", N Engl J Med, 337, pp.230~236 (1997)
106. Ubbink JB, "Vitamin requirements for the treatment of hyperhomocysteinemia in humans", J Nutr, 124, pp.1927~1933 (1994)
107. Landgren F, "Plasma homocysteine in acute myocardial infarction : homocysteine-lowering effect of folic acid", J Intern Med, 237, pp.381~388 (1995)
108. Homocysteine Lowering Trialists’ Collaboration, "Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists’ Collaboration", BMJ, 316, pp.894~898 (1998)
109. Malinow MR, "Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease", N Engl J Med, 338, pp.1009~1015 (1998)
110. Quinlivan EP, "Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease", Lancet, 359, pp.227~228 (2002)
111. Lee BJ, "Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease", Eur J Clin Nutr, 58, pp.481~487 (2004)
112. Homocysteine Lowering Trialists’ Collaboration, "Dose-dependent effects of folic acid on blood concentrations of homocysteine : a metaanalysis of the randomized trials", Am J Clin Nutr, 82, pp.806~812 (2005)
113. Hodis HN, "High-dose B vitamin supplementation and progression of subclinical atherosclerosis : a randomized controlled trial", Stroke, 40, pp.730~736 (2009)
114. Kim BJ, "Plasma homocysteine and coronary artery calcification in Korean men", Eur J Prev Cardiol, 22, pp.478~485 (2015)
115. Joo NS, "Cut-offvalue of serum homocysteine in relation to increase of coronary artery calcification", J Investig Med, 69, pp.345~350 (2021)
116. Held C, "Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals : baseline data from the Homocysteine and Atherosclerosis Reduction Trial(HART)", Vasc Med, 13, pp.245~253 (2008)
117. Jacques PF, "The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene", J Nutr, 132, pp.283~288 (2002)
118. Heese P, "Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin : results from the German Investigation on Neurobiology in Alcoholism(GINA)", Alcohol Alcohol, 47, pp.497~500 (2012)
119. Wilcken DE, "B vitamins and homocysteine in cardiovascular disease and aging", Ann N Y Acad Sci, 854, pp.361~370 (1998)
120. Olthof MR, "Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women", J Nutr, 133, pp.4135~4138 (2003)
121. Steenge GR, "Betaine supplementation lowers plasma homocysteine in healthy men and women", J Nutr, 133, pp.1291~1295 (2003)
122. Bidulescu A, "Usual choline and betaine dietary intake and incident coronary heart disease : the Atherosclerosis Risk in Communities(ARIC)Study", BMC Cardiovasc Disord, 7, pp.20~ (2007)
123. Dalmeijer GW, "Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women", Eur J Clin Nutr, 62, pp.386~394 (2008)
124. Lever M, "Betaine and secondary events in an acute coronary syndrome cohort", PLoS One, 7, pp.e37883~ (2012)
125. Amer M, "The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults", J Clin Endocrinol Metab, 99, pp.633~638 (2014)
126. Al-Bayyari N, "Vitamin D3 prevents cardiovascular diseases by lowering serum total homocysteine concentrations in overweight reproductive women : a randomized, placebo-controlled clinical trial", Nutr Res, 59, pp.65~71 (2018)
127. Young KA, "Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes", Diabetes Care, 34, pp.454~458 (2011)
128. Thiele I, "Associations between calcium and vitamin D supplement use as well as their serum concentrations and subclinical cardiovascular disease phenotypes", Atherosclerosis, 241, pp.743~751 (2015)
129. Mao PJ, "Effect of calcium or vitamin D supplementation on vascular outcomes : a meta-analysis of randomized controlled trials", Int J Cardiol, 169, pp.106~111 (2013)
130. Kheiri B, "Vitamin D deficiency and risk of cardiovascular diseases : a narrative review", Clin Hypertens, 24, pp.9~ (2018)
131. Barbarawi M, "Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials : a metaanalysis", JAMA Cardiol, 4, pp.765~776 (2019)
132. Park KY, "Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke", Cerebrovasc Dis, 40, pp.73~80 (2015)
133. Kriebitzsch C, "1, 25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase", J Bone Miner Res, 26, pp.2991~3000 (2011)
134. Luo G, "Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein", Nature, 386, pp.78~81 (1997)
135. Booth SL, "Determinants of vitamin K status in humans", Vitam Horm, 78, pp.1~22 (2008)
136. Berkner KL, "The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis", J Thromb Haemost, 2, pp.2118~2132 (2004)
137. Vermeer C, "Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase", Biochem J, 266, pp.625~636 (1990)
138. Lanham-New SA, "Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment", Proc Nutr Soc, 67, pp.163~176 (2008)
139. van Ballegooijen AJ, "The role of vitamin K status in cardiovascular health : evidence from observational and clinical studies", Curr Nutr Rep, 6, pp.197~205 (2017)
140. Geleijnse JM, "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease : the Rotterdam Study", J Nutr, 134, pp.3100~3105 (2004)
141. Shea MK, "Vitamin K supplementation and progression of coronary artery calcium in older men and women", Am J Clin Nutr, 89, pp.1799~1807 (2009)
142. Beulens JW, "High dietary menaquinone intake is associated with reduced coronary calcification", Atherosclerosis, 203, pp.489~493 (2009)
143. Gast GC, "A high menaquinone intake reduces the incidence of coronary heart disease", Nutr Metab Cardiovasc Dis, 19, pp.504~510 (2009)
144. Vossen LM, "Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease : rationale and study protocol(VitaK-CAC Trial)", Nutrients, 7, pp.8905~8915 (2015)
145. Schurgers LJ, "Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype", PLoS One, 7, pp.e43229~ (2012)
146. Westenfeld R, "Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients : a randomized trial", Am J Kidney Dis, 59, pp.186~195 (2012)
147. Bjorklund G, "The role of matrix Gla protein(MGP)in vascular calcification", Curr Med Chem, 27, pp.1647~1660 (2020)
148. Schurgers LJ, "Vitamin K : key vitamin in controlling vascular calcification in chronic kidney disease", Kidney Int, 83, pp.782~784 (2013)

관련 논문AI추천